The NTIS website and supporting ordering systems are undergoing a major upgrade from 8PM on September 25th through approximately October 6. During that time, much of the functionality, including subscription and product ordering, shipping, etc., will not be available. You may call NTIS at 1-800-553-6847 or (703) 605-6000 to place an order but you should expect delayed shipment. Please do NOT include credit card numbers in any email you might send NTIS.
Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website http://www.gpo.gov/fdsys; (3) the federal government Internet portal USA.gov; or (4) a web search conducted using a commercial search engine such as http://www.google.com.
Accession Number ADA566862
Title Noninvasive Assessment of Renal Tumor Aggressiveness Using Hyperpolarized 13C MR.
Publication Date Jul 2012
Media Count 11p
Personal Author Z. Wang
Abstract The incidence of renal cell carcinomas (RCCs) has risen significantly in the last 20 years. There is currently a critical unmet need for noninvasive biomarkers that can confidently predict the biological behavior of renal tumors in order to improve their accurate diagnosis and rational selection of treatment options. The goal of this pre-clinical study is to identify clinically translatable hyperpolarized 13C markers of RCC aggressiveness using established cell lines. In this work, we compared the metabolism of living immortalized cells derived from a localized renal cell carcinoma (RCC), and a metastatic RCC using hyperpolarized 13C pyruvate MR in a MR compatible bioreactor. We showed that the observed hyperpolarized pyruvate to lactate flux in these cells is likely influenced by a combination of factors including the enzyme lactate dehydrogenase (LDH), and the monocarboxylate transporters (MCT) 1 and 4 which transport pyruvate and lactate respectively. We further demonstrated that cells derived from the metastatic RCC have increased export of hyperpolarized lactate to the extracellular space compared to the cells derived from the localized RCC, and that such differences are likely mediated by the differential expression of MCT4. These results suggest that the assessment of lactate production and export using clinically translatable hyperpolarized probes has the potential to improve the noninvasive characterization of renal tumor aggressiveness.
Keywords Behavior
Cancer
Cells(Biology)
Enzymes
Growth(Physiology)
Hyperpolarized 13c mr
Kidneys
Lactic dehydrogenase
Metastasis
Pyruvates
Renal cell carcinoma
Tumor aggressiveness


 
Source Agency Non Paid ADAS
NTIS Subject Category 57A - Anatomy
57S - Physiology
57E - Clinical Medicine
Corporate Author California Univ., San Francisco.
Document Type Technical report
Title Note Final rept. 15 Jun 2011-14 Jun 2012.
NTIS Issue Number 1307
Contract Number W81XWH-11-1-0383

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader